Teva Branded Pharmaceutical Products R&d Llc

This study is testing whether an oral medication called TEV-56286 can help control the progression of multiple system atrophy (MSA), a rare and serious neurological disorder. The trial will involve 350 adults with MSA who will take either the drug or a placebo for 48 weeks. Resea…

This study continues testing an oral medication called TEV-56286 for people with multiple system atrophy (MSA), a rare and progressive brain disorder. It follows 200 participants from a previous trial to monitor the drug's long-term safety over approximately two years. The main g…

This study is testing a new combination inhaler (containing fluticasone and albuterol) to see if it works better than a standard albuterol inhaler at preventing severe asthma attacks that require emergency care or steroids. It will involve about 2700 adults and children with asth…

This study is testing an investigational drug called TEV-53408 to see if it can protect the gut lining in adults with celiac disease when they are exposed to gluten. The trial will involve about 48 participants who will take the drug or a placebo while undergoing controlled glute…